Stockscreener 앱 받기
2.00%
시간 외 거래:
전일 마감가:
$2.00
열려 있는:
$1.99
하루 거래량:
170.35K
Relative Volume:
0.79
시가총액:
$119.56M
수익:
$14.18M
순이익/손실:
$-82.66M
주가수익비율:
-1.5154
EPS:
-1.3
순현금흐름:
$-50.80M
1주 성능:
-2.00%
1개월 성능:
-15.15%
6개월 성능:
+15.98%
1년 성능:
+3.16%
1일 변동 폭
$1.96
$2.03
1주일 범위
$1.875
$2.03
52주 변동 폭
$1.56
$2.625
시어 Stock (SEER) Company Profile
명칭
Seer Inc
전화
650-453-0000
주소
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
SEER을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.97 | 119.56M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.51 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
시어 Stock (SEER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-08-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-12-29 | 개시 | BofA Securities | Neutral |
| 2020-12-29 | 개시 | Cowen | Outperform |
| 2020-12-29 | 개시 | JP Morgan | Overweight |
| 2020-12-29 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
시어 주식(SEER)의 최신 뉴스
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - Marketscreener.com
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance Australia
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
Revolutionary Cancer Therapy Platform: How Seer's Proteomics Technology is Reshaping Treatment Research - StockTitan
Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER) - MarketBeat
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Seer To Report Fourth Quarter And Full Year 2024 Financial Results On February 27, 2025 - Barchart
Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS) Shares Down 1.1% – What’s Next? - Armenian Reporter
Omid Farokhzad Sells 8,068 Shares of Seer, Inc. (NASDAQ:SEER) Stock - Armenian Reporter
Citrine Capital LLC Buys Shares of 24,875 Dimensional U.S. Equity ETF (NYSEARCA:DFUS) - Armenian Reporter
CSX Co. (NASDAQ:CSX) Shares Acquired by Glassy Mountain Advisors Inc. - Armenian Reporter
Sompo (OTCMKTS:SMPNY) Reaches New 1-Year High – Should You Buy? - Armenian Reporter
Illumina (ILMN) Q4 Earnings Miss Estimates - Yahoo Finance
Seer CEO Omid Farokhzad sells $18,044 in stock - MSN
Seer Inc.'s president and CFO David Horn sells $7,939 in stock - MSN
ResMed Inc Director Plans Sale of 2,000 Shares - MSN
Seer CEO Omid Farokhzad sells $18,044 in stock By Investing.com - Investing.com Nigeria
Seer Inc.’s president and CFO David Horn sells $7,939 in stock - Investing.com Nigeria
Seer, Inc. (NASDAQ:SEER) Stake Boosted by JPMorgan Chase & Co. - Defense World
Al Seer Marine reports revenue of AED1.281 billion in 2024 - MSN
Stock Yards Bancorp, Inc. Issues Press Release Announcing Earnings for Q4 2024 - Defense World
FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by Barclays PLC - Defense World
시어 (SEER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
시어 주식 (SEER) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
| Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
0.49%
1.87%
자본화:
|
볼륨(24시간):